← Open Payments lookup

DIANE NARAINE: Open Payments

NPI 1972080612 · CLIFTON, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,096 in 146 payments from 22 companies in 2025. Trend: 2023 $2,646 · 2024 $3,558 · 2025 $3,096

Food & beverage: $2,262Honoraria: $750Education: $84
CompanyPaymentsAmount
QOL Medical, LLC11$958
ABBVIE INC.41$506
Janssen Biotech, Inc.22$309
Salix Pharmaceuticals, a division of Bausch Health US, LLC12$216
Ipsen Biopharmaceuticals, Inc7$189
Madrigal Pharmaceuticals4$149
Aimmune Therapeutics, Inc.6$111
Takeda Pharmaceuticals U.S.A., Inc.5$88
Lilly USA, LLC5$87
VIVUS LLC4$70

Products named: Sucraid, TREMFYA, RINVOQ, XIFAXAN, IQIRVO, REZDIFFRA, ZENPEP, CREON.

Industry payments across NJ — which companies pay providers there.